204 related articles for article (PubMed ID: 19538180)
1. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
2. CD28 stimulation triggers NF-kappaB activation through the CARMA1-PKCtheta-Grb2/Gads axis.
Takeda K; Harada Y; Watanabe R; Inutake Y; Ogawa S; Onuki K; Kagaya S; Tanabe K; Kishimoto H; Abe R
Int Immunol; 2008 Dec; 20(12):1507-15. PubMed ID: 18829987
[TBL] [Abstract][Full Text] [Related]
3. Structure and expression pattern of teleost caspase recruitment domain (CARD) containing proteins that are potentially involved in NF-kappaB signalling.
Chang MX; Chen WQ; Nie P
Dev Comp Immunol; 2010 Jan; 34(1):1-13. PubMed ID: 19699229
[TBL] [Abstract][Full Text] [Related]
4. CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.
Wegener E; Krappmann D
Sci STKE; 2007 May; 2007(384):pe21. PubMed ID: 17473310
[TBL] [Abstract][Full Text] [Related]
5. Interaction of calmodulin with Bcl10 modulates NF-kappaB activation.
Edin S; Oruganti SR; Grundström C; Grundström T
Mol Immunol; 2010 Jul; 47(11-12):2057-64. PubMed ID: 20439115
[TBL] [Abstract][Full Text] [Related]
6. Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.
Lobry C; Lopez T; Israël A; Weil R
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):908-13. PubMed ID: 17213322
[TBL] [Abstract][Full Text] [Related]
7. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB signaling in lymphocytes: a new cast of characters.
Lucas PC; McAllister-Lucas LM; Nunez G
J Cell Sci; 2004 Jan; 117(Pt 1):31-9. PubMed ID: 14657271
[TBL] [Abstract][Full Text] [Related]
10. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
[TBL] [Abstract][Full Text] [Related]
11. Protein-protein interactions: a simple strategy to identify binding sites and peptide antagonists.
Sandomenico A; Monti SM; Sabatella M; De Capua A; Tornatore L; Doti N; Viparelli F; Dathan NA; Pedone C; Ruvo M; Marasco D
Chem Biol Drug Des; 2009 May; 73(5):483-93. PubMed ID: 19366357
[TBL] [Abstract][Full Text] [Related]
12. Post-translational modifications regulate distinct functions of CARMA1 and BCL10.
Thome M; Weil R
Trends Immunol; 2007 Jun; 28(6):281-8. PubMed ID: 17468049
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Bcl10-mediated activation of NF-kappa B by BinCARD, a Bcl10-interacting CARD protein.
Woo HN; Hong GS; Jun JI; Cho DH; Choi HW; Lee HJ; Chung CW; Kim IK; Jo DG; Pyo JO; Bertin J; Jung YK
FEBS Lett; 2004 Dec; 578(3):239-44. PubMed ID: 15637807
[TBL] [Abstract][Full Text] [Related]
14. CARD6 is interferon inducible but not involved in nucleotide-binding oligomerization domain protein signaling leading to NF-kappaB activation.
Dufner A; Duncan GS; Wakeham A; Elford AR; Hall HT; Ohashi PS; Mak TW
Mol Cell Biol; 2008 Mar; 28(5):1541-52. PubMed ID: 18160713
[TBL] [Abstract][Full Text] [Related]
15. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
McCully RR; Pomerantz JL
Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
[TBL] [Abstract][Full Text] [Related]
16. Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
Park JH; Bae JY; Park HH
Int J Mol Med; 2013 May; 31(5):1280-7. PubMed ID: 23525237
[TBL] [Abstract][Full Text] [Related]
17. CARD9 versus CARMA1 in innate and adaptive immunity.
Hara H; Saito T
Trends Immunol; 2009 May; 30(5):234-42. PubMed ID: 19359218
[TBL] [Abstract][Full Text] [Related]
18. NDPP1 is a novel CARD domain containing protein which can inhibit apoptosis and suppress NF-kappaB activation.
Zhang H; Fu W
Int J Oncol; 2002 May; 20(5):1035-40. PubMed ID: 11956601
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide activates NF-kappaB by TLR4-Bcl10-dependent and independent pathways in colonic epithelial cells.
Bhattacharyya S; Dudeja PK; Tobacman JK
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G784-90. PubMed ID: 18718996
[TBL] [Abstract][Full Text] [Related]
20. Determining the destiny of NF-kappa B after TCR ligation: it's CARMA1.
Bunnell SC
Mol Interv; 2002 Oct; 2(6):356-60, 338. PubMed ID: 14993411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
